Please login to the form below

Not currently logged in
Email:
Password:

Divestment

This page shows the latest Divestment news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

Takeda’s continued divestment of select assets aligns with the company’s efforts to focus on its chosen business areas. ... As well as completing $10bn in divestment transactions, Takeda has made other sacrifices for the Shire acquisition, including

Latest news

More from news
Approximately 6 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Teva/Alder Biopharmaceuticals patent settlement. We have featured Teva in Deal Watch over the last few months but focused more on the company's divestment activities to tackle its debt

  • Deal Watch February 2017 Deal Watch February 2017

    The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan, ... Sanofi's $88.3m deal with Ipsen covers the

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Out-partnering deals included the $1.1bn licence to LEO for tralokinumab in skin diseases and the $1bn divestment to Pfizer of its late-stage small molecule anti-infective business. ... will contribute to a decline in the number of M&A deals over $5bn,

  • Deal Watch January 2017 Deal Watch January 2017

    1, 600. Valeant. L'Oreal. Divestment. CeraVe AcneFree AMBI. 1, 300. Forward Pharma. ... 960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820. Delinia. Celgene.

  • Deal Watch October 2016 Deal Watch October 2016

    They must have been working eight days a week! Core therapy area acquisitions and non-core divestments are changing the shape of AstraZeneca. ... The Month of Divestments – We Can Work It Out. At least AstraZeneca are making a proactive approach to

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics